Related Experiment Video
Updated: Feb 26, 2026

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
Published on: August 24, 2019
Oral prednisolone for 4 days does not increase exercise tolerance in men with COPD
S L Karlsson1, V Backer2, Nina Skavlan Godtfredsen1
11 Department of Respiratory Medicine, Hvidovre University Hospital, Hvidovre, Denmark.
Systemic corticosteroids, commonly used for acute exacerbations of chronic obstructive pulmonary disease (COPD), may improve muscle strength. This study found prednisolone increased quadriceps muscle strength in COPD patients, suggesting a potential benefit beyond respiratory function.
Area of Science:
- Pulmonary Medicine
- Exercise Physiology
- Pharmacology
Background:
- Chronic obstructive pulmonary disease (COPD) management focuses on preventing lung function decline and reducing acute exacerbations (AECOPD).
- Systemic corticosteroids are a standard treatment for AECOPD, but their effects on exercise performance and muscle fatigue are less understood.
- This study investigated the impact of oral prednisolone on exercise capacity and muscle function in severe to very severe COPD patients.
Discussion:
- While oral corticosteroids did not improve time to exhaustion or lung function in COPD patients, they significantly enhanced maximal voluntary contraction (MVC) of the quadriceps femoris muscle.
- This suggests that corticosteroids may have a direct positive effect on skeletal muscle strength, even during submaximal endurance activities.
- The findings indicate a potential benefit of corticosteroids in mitigating muscle fatigue and improving muscle performance in COPD patients.
Key Insights:
- Oral prednisolone treatment for 5 days significantly increased quadriceps muscle strength (MVC) in patients with severe to very severe COPD.
- No significant differences were observed in time to exhaustion, lung function, or maximal respiratory pressures between the prednisolone and placebo groups.
- Corticosteroids appear to impact muscle groups subjected to submaximal endurance exercise, independent of improvements in overall exercise tolerance or lung function.
Outlook:
- Further research is warranted to explore the long-term effects of corticosteroids on muscle function and exercise capacity in COPD.
- Investigating the specific mechanisms by which corticosteroids enhance muscle strength in COPD could lead to targeted therapeutic strategies.
- This study opens avenues for considering corticosteroid therapy not only for AECOPD management but also for improving the physical function and quality of life in COPD patients.
More Related Videos
08:44Author Spotlight: Integrating Alveolar-Capillary Reserve Measurements in Exercise Adaptation and Therapeutic Strategies
Published on: February 2, 2024
04:24Acupoint Application as a Traditional Chinese Medicine Treatment for Fatigue Associated with Chronic Obstructive Pulmonary Disease
Published on: September 5, 2025
Related Concept Videos
COPD: Management Using Bronchodilators and Corticosteroids
Exercise and Cardiovascular Response
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Chronic Obstructive Pulmonary Disease-I: Introduction